2seventy bio (TSVT)

• Market cap: $162M
• 1 day: 7.53%
• 5 days: -4.27%
• 1 month: 0.96%
• 3 months: -37.82%
• 6 months: -16.49%
• Year to date: -23.41%
• 1 year: -7.10%
• 5 years: -77.20%
• 10 years: -77.20%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: 2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

Employees: 425

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

695% more call options, than puts

Call options by funds: $739K | Put options by funds: $93K

9% more capital invested

Capital invested by funds: $196M [Q2] → $213M (+$16.7M) [Q3]

0% more funds holding

Funds holding: 113 [Q2] → 113 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 14

11.58% less ownership

Funds ownership: 98.98% [Q2] → 87.41% (-11.58%) [Q3]

32% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 37

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]